Hill Top Research positions itself for growth

By Kirsty Barnes

- Last updated on GMT

Hill Top Research, one of the leading clinical research services
companies in the US, has positioned itself for growth after last
week's acquisition by Utah's DW Healthcare Partners, a private
equity firm focused on the healthcare industry.

The acquisition, financed with $8 million in equity from >DWHP​ and additional debt financing from a third party provider, will allow Hill Top to expand capacity within the pharmaceutical services market, add new technical capabilities, and provide the funds for possible industry acquisitions, according to the company.

The new company will be called Hill Top Acquisition Corp. and will continue to do business as >Hill Top Research,​ offering a range of clinical research services, including safety testing, efficacy testing, sensory testing, claim substantiation, data management, project management, and microbiology.

"This investment enhances our ability to continue to offer clinical research expertise and subject recruiting at our multiple locations throughout North America. In addition, we can continue to invest in providing high quality clinical studies for our clients," said Joel Ivers, Hill Top COO.

In conjunction with the acquisition announcement, Hill Top also announced that its CEO of 20 years, Jim Pearce, has now retired and will be replaced by current COO Joel Ivers.

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars